Tovorafenib Patent Expiration
Tovorafenib was first introduced by Day One Biopharmaceuticals Inc
Tovorafenib Patents
Given below is the list of patents protecting Tovorafenib, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ojemda | US10426782 | Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation | Jun 23, 2035 | Day One Biopharms |
| Ojemda | US8293752 | Compounds useful as Raf kinase inhibitors | Aug 04, 2031 | Day One Biopharms |
Tovorafenib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List